Show All
Media Videos
Presentations
News
Person looking down microscope in lab

The Future of Medicine Advancement

Sean Hall on The Ari Zoldan Show with Mel Engle & Pamela Bush to discuss the future of medicine advancement


Friday 1st April 2022

Read more

A new focus on patient suffering

Even in today’s world of exponential technology and wonder drugs, patients all over the world still have extreme, desperate experiences.


Wednesday 16th February 2022

Read more
Transforming into pure-play biotech

Transforming into a pure-play biotech

With lead product NanaBis™ (NanoCelle® encapsulated 50:50 THC:CBD for pain) preparing to enter a Phase III trial in pain, management has decided to fully focus on therapeutics development and divested its nutraceuticals portfolio


Monday 31st January 2022

Read more
RNA

Government grant to apply NanoCelle® to an RNA nasal vaccine

Medlab (ASX:MDC) receives Government grant to apply NanoCelle® to an RNA nasal vaccine in collaboration with University of NSW (UNSW) and Macquarie University (MQ) to fight COVID-19 future potential epidemics.


Friday 14th January 2022

Read more
Medlab Investor News March 2022

Global Investor News March 2022

Bimonthly Medlab news. This month: a note from our CEO, a research note from Morgan’s and UK NanaBis and NanoCBD.


Tuesday 11th January 2022

Read more
Now this is scalable – a drug delivery platform rather than a drug itself

Now this is scalable – a drug delivery platform rather than a drug itself

Listen to ASX-listed Medlab Clinical CEO Dr Sean Hall talk to Matt Birney on the Bulls N’ Bears Report on Deb Knight show on 873 am. (2GB), about Medlab’s development of a potent drug delivery platform that can potentially piggyback any drug to where it needs to go.


Friday 12th November 2021

Read more

Medlab Clinical Ltd (ASX:MDC) sells its Australian nutraceutical business to PharmaCare

We are pleased to announce the sale of the Australian-only part of its nutraceutical business to PharmaCare


Wednesday 27th October 2021

Read more

Annual Message to Shareholders October 2021

Once Medlab Clinical’s listing on the ASX six years ago its experienced team of scientists have made extraordinary advances in the creation and manufacture of unique, world-leading products and valuable intellectual property.


Wednesday 13th October 2021

Read more

Edison Group – Executive interview with CEO, Dr Sean Hall

In this video, Dr Sean Hall, Medlab’s co-founder and CEO, introduces us to Medlab and its lead programmes and discusses what we can expect from this fast-growing company over the coming months.


Sunday 29th August 2021

Read more

Jefferies Healthcare Conference - 2021

Medlab outlines its growth strategy for US and global investors at the prestigious annual Jefferies Healthcare Conference.


Saturday 26th June 2021

Read more

Medlab Clinical talks upcoming Phase III NanaBis trial and NanoCelle partnering opportunities

Medlab Clinical Ltd's (ASX:MDC) Dr Sean Hall tells Proactive's Andrew Scott they're focused on achieving regulatory approval for its lead drug candidate NanaBis™.


Thursday 24th June 2021

Read more

Small Caps interview of CEO Sean Hall

Small Caps interview of CEO Sean Hall


Thursday 22nd April 2021

Read more